Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐ and high‐stage tumours

Documenti analoghi

• Prognostic performance of FIGO 2023 endometrial carcinoma staging: a comparison to FIGO 2009 staging in the setting of known and unknown molecular classification
  di: Diane Libert, et al.
  Pubblicazione: (2024)
• Folate receptor alpha ( FRα / FOLR1 ) and HER2 immunohistochemical staining in high‐grade endometrial carcinoma with aberrant p53 expression
  di: Austin McHenry, et al.
  Pubblicazione: (2025)
• The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile
  di: Mona Alafraidi, et al.
  Pubblicazione: (2024)
• Hiding in plain sight: DICER1 ‐associated yolk sac tumour masquerading as an endometrioid carcinoma of the ovary
  di: Lili Fu, et al.
  Pubblicazione: (2026)
• Novel prognostic nomogram for predicting recurrence‐free survival in medullary thyroid carcinoma
  di: Yagiz A Aksoy, et al.
  Pubblicazione: (2024)